Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

GUSTO investigation

Lee KL, Woodlief LH, Topol EJ et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction results from an international trial of 41,021 patients. GUSTO Investigators. Circulation 1995 91 1659. [Pg.317]

Newby KH, Thompson T, Stebbins A et al. Sustained ventricular arrhythmias in patients receiving thrombolytic therapy incidence and outcomes. The GUSTO Investigators. Circulation 1998 98 2567. [Pg.319]

The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993 329(10) 673-82. [Pg.42]

The GUSTO Investigators. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein Ilb/IIIa inhibition the GUSTO V randomised trial. Lancet 2001 357 1905-1914. [Pg.204]

Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction results from the GUSTO-lib Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-lib) Investigators. J Am Coll Cardiol, 1998.31(7) 1493-8. [Pg.255]

The GUSTO-IV ACS Investigators. Effect of glycoprotein llb/IIIA receptor blocker abciximab on outcome of patients with acute coronary syndromes without early revascularization the GUSTO-IV ACS randomized trial. Lancet 2001 357 1915-1924. [Pg.55]

The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO I la) Investigators. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. Circulation 1994 90 1631-1637. [Pg.107]

GUSTO II b Investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 1996 335 775-782. [Pg.107]

Crenshaw BS, Granger CB, Birnbaum Y, et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-1 (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation 2000 101(1 ) 27—32. [Pg.602]

Aylward PE, Wilcox RG, Horgan JH, White HD, Granger CB, Califf RM, Topol EJ. Relation of increased arterial blood pressure to mortahty and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators. Ann Intern Med 1996 125(ll) 891-900. [Pg.3407]

The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N... [Pg.62]

Newby LK, Rutsch WR, CaUff RM, et al. for the GUSTO-I Investigators. Time from symptom onset to treatment and outcomes after thrombolytic therapy. J Am Coll Cardiol 1996 27 1646-1655. [Pg.114]

See other pages where GUSTO investigation is mentioned: [Pg.313]    [Pg.316]    [Pg.313]    [Pg.316]    [Pg.252]    [Pg.91]    [Pg.123]    [Pg.125]    [Pg.314]    [Pg.315]    [Pg.315]    [Pg.322]    [Pg.289]    [Pg.32]    [Pg.35]    [Pg.24]    [Pg.106]    [Pg.115]   
See also in sourсe #XX -- [ Pg.252 ]



SEARCH



© 2024 chempedia.info